Cargando…
The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders
Background: Gilles de la Tourette syndrome (TS) is a chronic neuropsychiatric disorder characterized by motor and vocal tics. First-line treatments for tics are antipsychotics and tic-specific behavioral therapies. However, due to a lack of trained therapists and adverse events of antipsychotic medi...
Autores principales: | Jakubovski, Ewgeni, Pisarenko, Anna, Fremer, Carolin, Haas, Martina, May, Marcus, Schumacher, Carsten, Schindler, Christoph, Häckl, Sebastian, Aguirre Davila, Lukas, Koch, Armin, Brunnauer, Alexander, Cimpianu, Camelia Lucia, Lutz, Beat, Bindila, Laura, Müller-Vahl, Kirsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725747/ https://www.ncbi.nlm.nih.gov/pubmed/33324255 http://dx.doi.org/10.3389/fpsyt.2020.575826 |
Ejemplares similares
-
Implications for blinding in clinical trials with THC-containing cannabinoids based on the CANNA-TICS trial
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2022) -
Reply: A call for caution: ‘stop that’ sentiments threaten tic research, healthcare and advocacy progress
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2022) -
Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols
por: Kanaan, Ahmad Seif, et al.
Publicado: (2017) -
ONLINE-TICS: Internet-Delivered Behavioral Treatment for Patients with Chronic Tic Disorders
por: Haas, Martina, et al.
Publicado: (2022) -
Tic disorders revisited: introduction of the term “tic spectrum disorders”
por: Müller-Vahl, Kirsten R., et al.
Publicado: (2019)